NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Languages English Remove constraint Languages: English Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

591. E6(R2) good clinical practice: integrated addendum to ICH E6(R1)

592. M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk

593. E18 genomic sampling and management of genomic data

594. Chronic obstructive pulmonary disease: use of the St. George's Respiratory Questionnaire as a PRO assessment tool

595. Liposome drug products: chemistry, manufacturing, and controls : human pharmacokinetics and bioavailability : and labeling documentation

596. E11(R1) addendum: clinical investigation of medicinal products in the pediatric population

597. Considerations for design, development, and analytical validation of next generation sequencing (NGS)--based in vitro diagnostics (IVDs) intended to aid in the diagnosis of suspected germline diseases: guidance for stakeholders and Food and Drug Administration staff

598. Use of public human genetic variant databases to support clinical validity for genetic and genomic-based in vitro diagnostics: guidance for stakeholders and Food and Drug Administration staff

600. Q7 good manufacturing practice guidance for active pharmaceutical ingredients: questions and answers